MX171883B - Uso de glutaminato de piridoxal-5'-fosfato de magnesio para la elaboracion de composiciones farmaceuticas que sirven para la prevencion de enfermedades derivadas de lesiones vasculares - Google Patents

Uso de glutaminato de piridoxal-5'-fosfato de magnesio para la elaboracion de composiciones farmaceuticas que sirven para la prevencion de enfermedades derivadas de lesiones vasculares

Info

Publication number
MX171883B
MX171883B MX025919A MX2591991A MX171883B MX 171883 B MX171883 B MX 171883B MX 025919 A MX025919 A MX 025919A MX 2591991 A MX2591991 A MX 2591991A MX 171883 B MX171883 B MX 171883B
Authority
MX
Mexico
Prior art keywords
piridoxal
prevention
preparation
pharmaceutical compositions
magnesium phosphate
Prior art date
Application number
MX025919A
Other languages
English (en)
Inventor
Werner Schneider
Britta Meyer
Erich F Elstner
Original Assignee
Steigerwald Arzneimittelwerk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk filed Critical Steigerwald Arzneimittelwerk
Publication of MX171883B publication Critical patent/MX171883B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a uso de glutaminato de piridoxal-5'-fosfato de magnesio para la elaboración de composiciones farmaceuticas que sirven para la prevención de enfermedades derivadas de lesiones vasculares.
MX025919A 1990-05-25 1991-05-24 Uso de glutaminato de piridoxal-5'-fosfato de magnesio para la elaboracion de composiciones farmaceuticas que sirven para la prevencion de enfermedades derivadas de lesiones vasculares MX171883B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4016963A DE4016963A1 (de) 1990-05-25 1990-05-25 Verwendung von magnesium-pyridoxal-5'-phosphat-glutaminat zur verhinderung von erkrankungen, die sich infolge von gefaessschaeden ergeben

Publications (1)

Publication Number Publication Date
MX171883B true MX171883B (es) 1993-11-22

Family

ID=6407228

Family Applications (1)

Application Number Title Priority Date Filing Date
MX025919A MX171883B (es) 1990-05-25 1991-05-24 Uso de glutaminato de piridoxal-5'-fosfato de magnesio para la elaboracion de composiciones farmaceuticas que sirven para la prevencion de enfermedades derivadas de lesiones vasculares

Country Status (28)

Country Link
US (1) US5372999A (es)
EP (1) EP0458287B1 (es)
JP (1) JPH07119174B2 (es)
KR (1) KR970005180B1 (es)
CN (1) CN1050750C (es)
AT (1) ATE142884T1 (es)
AU (1) AU651108B2 (es)
CA (1) CA2043228C (es)
CZ (1) CZ280683B6 (es)
DE (2) DE4016963A1 (es)
DK (1) DK0458287T3 (es)
EG (1) EG19730A (es)
ES (1) ES2091262T3 (es)
GR (1) GR3021077T3 (es)
HR (1) HRP931445B1 (es)
HU (1) HU219223B (es)
IE (1) IE76728B1 (es)
IL (1) IL98156A (es)
IN (1) IN173057B (es)
LT (1) LT3335B (es)
LV (1) LV10046B (es)
MD (1) MD306C2 (es)
MX (1) MX171883B (es)
RU (1) RU2041713C1 (es)
SI (1) SI9110925A (es)
SK (1) SK278896B6 (es)
UA (1) UA26973A1 (es)
ZA (1) ZA913692B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19527820A1 (de) * 1995-07-28 1997-01-30 Leniger Follert Elfriede Prof Arzneimittel zur Behandlung von Ulcera, insbesondere bei arteriellen und venösen Durchblutungsstörungen der Extremitäten, bei chronisch venöser Insuffizienz und Lymphödem
DE19532625C2 (de) * 1995-09-04 2000-04-20 Steigerwald Arzneimittelwerk Verfahren zur Herstellung von Magnesium-pyridoxal-5'-phosphat-glutamat und dabei erhaltene Zwischenprodukte
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
AU763464B2 (en) 1999-03-08 2003-07-24 Medicure Inc. Pyridoxal analogues for vitamin B-6 disorders
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
EP1210117A2 (en) * 1999-08-24 2002-06-05 Medicure International Inc. Compositons for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
ATE293119T1 (de) 2000-02-29 2005-04-15 Medicure Int Inc Cardioprotektive phosphonate
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
WO2002004421A2 (en) 2000-07-07 2002-01-17 Medicure International Inc. Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
US7459468B2 (en) 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
CA2585165A1 (en) 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
JP2010535013A (ja) 2007-03-14 2010-11-18 シエラ モレキュラー コーポレイション 細胞および／または高分子の保存および／または安定化のための組成物、システムおよび方法
RU2484843C1 (ru) * 2012-04-03 2013-06-20 Алексей Кириллович Пехтерев Лекарственный сбор растений для лечения сердечно-сосудистых заболеваний

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE246172C (es)
DE2461742C2 (de) * 1974-12-28 1983-01-27 Steigerwald Arzneimittelwerk Gmbh, 6100 Darmstadt Pyridoxin-5'-phosphorsäureester-Derivate sowie deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3807895A1 (de) * 1988-03-10 1989-09-21 Knoll Ag Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker

Also Published As

Publication number Publication date
EP0458287B1 (en) 1996-09-18
MD306B1 (ro) 1995-10-31
DK0458287T3 (da) 1996-10-07
UA26973A1 (uk) 2000-02-28
EP0458287A2 (en) 1991-11-27
ATE142884T1 (de) 1996-10-15
US5372999A (en) 1994-12-13
DE4016963C2 (es) 1992-04-30
IL98156A (en) 1996-06-18
KR910019616A (ko) 1991-12-19
HRP931445B1 (en) 2000-04-30
EG19730A (en) 1996-01-31
JPH04235130A (ja) 1992-08-24
LT3335B (en) 1995-07-25
IE911783A1 (en) 1991-12-04
IN173057B (es) 1994-02-05
HU219223B (en) 2001-03-28
KR970005180B1 (ko) 1997-04-14
CA2043228A1 (en) 1991-11-26
IL98156A0 (en) 1992-06-21
HRP931445A2 (en) 1996-02-29
ES2091262T3 (es) 1996-11-01
HU911756D0 (en) 1991-12-30
CS156391A3 (en) 1992-02-19
DE4016963A1 (de) 1991-11-28
AU651108B2 (en) 1994-07-14
ZA913692B (en) 1992-02-26
CN1050750C (zh) 2000-03-29
SI9110925A (sl) 1998-06-30
IE76728B1 (en) 1997-11-05
CZ280683B6 (cs) 1996-04-17
CN1057391A (zh) 1992-01-01
LV10046A (lv) 1994-05-10
CA2043228C (en) 1998-07-14
JPH07119174B2 (ja) 1995-12-20
DE69122170T2 (de) 1997-02-20
SK278896B6 (sk) 1998-04-08
LTIP580A (en) 1994-12-27
EP0458287A3 (en) 1992-04-08
RU2041713C1 (ru) 1995-08-20
HUT58204A (en) 1992-02-28
DE69122170D1 (de) 1996-10-24
MD306C2 (ro) 1996-02-29
AU7730191A (en) 1991-11-28
GR3021077T3 (en) 1996-12-31
LV10046B (en) 1995-02-20

Similar Documents

Publication Publication Date Title
MX171883B (es) Uso de glutaminato de piridoxal-5'-fosfato de magnesio para la elaboracion de composiciones farmaceuticas que sirven para la prevencion de enfermedades derivadas de lesiones vasculares
MX9603560A (es) Composiciones de prostaglandinas estables en almacenamiento.
CA2122271A1 (en) Use of Salicylic Acid for Regulating Skin Wrinkles and/or Skin Atrophy
BG103335A (en) Application of fumaric acid derivatives
DE69638351D1 (de) Sowie zur resektion des distalen und vorderen femurs
GR3006815T3 (es)
ZA90966B (en) Oxidized diphenylheteroalkanes,the preparation and use thereof
SE8904354D0 (sv) A pharmaceutical composition
ES2136167T3 (es) Composiciones de idebenona para tratar la enfermedad de alzheimer.
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
ES2181054T3 (es) Utilizacion de producto(s) proteico(s) kgf y de producto(s) proteico(s) glp-2 para la preparacion de un medicamento.
AU1085392A (en) Alkyl ether carboxylic acid taurides
GR3007508T3 (es)
ATE92751T1 (de) Oral-praeparate.
ES2059756T3 (es) Composiciones farmaceuticas que contienen primicina.
NZ238124A (en) Heterocyclylalkylphosphonic acid and ester derivatives and pharmacueitcal compositions
ZA944281B (en) Use of efaroxan and its derivatives for the preparation of a medicinal product intented for the treatment of parkinson's disease
CA2183764A1 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
IT1238692B (it) Composizioni farmaceutiche a base di calcitonina per la somministrazione sublinguale
ZA935120B (en) Medicinal compositions for the improvement of blood coagulation comprising TCF-II